'Covid is not going away': Virologist fund manager Dr Ogden on coronavirus, healthcare valuations and biotech opportunities
Single vaccine 'not enough' to treat patients
Sustainable Development Goals are a matter of urgency
Acacia Research Corporation in talks with Link Fund Solutions
Eye on large-cap pharma and biotech
Fire sale could be forthcoming
Gold funds were worst performers
US healthcare benefitting from secular tailwinds
What should investors look out for?
Best-performing fund over five years
'Wobbling risk appetite'
Industry Voice: Biotech companies are increasingly pioneering groundbreaking therapies for diseases with high unmet medical need. Investing in these innovation leaders is a hallmark of BB Biotech'sinvestment philosophy.
Big sustainability challenges being tackled
Four types of asset categories
The healthcare sector has been under a black cloud since the US Presidential Election last year, driven by concerns over drug pricing.
Equity markets performed well in the first quarter driven by an expectation of lower corporate tax rates in the US and the potential repatriation of offshore cash and investments in infrastructure.
Which trusts were analyst favourites for the year?